HOME
  COMPANY
  SERVICES
  CAREERS
  LOCATIONS
  LINKS
 


   




Follow Up Survey

Adult Satisfaction Survey (unavailable)
Child Satisfaction Survey (unavailable)

 

 
 

YOUR SATISFACTION COUNTS

The Harbor sets many goals each year. One goal that continues to be a priority is your satisfaction. We value your comments regarding what we do well and what we can improve. Last year your feedback told us that 97% of persons receiving services from the Harbor were satisfied with their treatment and would refer families and friends. Although it is likely that at some time during treatment you will be asked to provide us your feedback about how we are doing, you are welcome at any time to complete a Satisfaction Survey and place it in the drop box in the lobby or give it to any Harbor employee.

.........................................................................................................................

Medicaid Changes in Prescriptions

In the last issue of Harbor Happenings we shared with you the changes in the Florida Medicaid program regarding Managed Care options. This issue focuses on changes that may effect the medications you have been prescribed.

Medicaid recently established a Preferred Drug List (PDL) for all Medicaid recipients. For the first time this includes Mental Health Medications. If you are enrolled in a Managed Medicaid Program, the approved medication list must be NO MORE RESTRICTIVE than those that do not have a Managed Medicaid policy. The PDL has limited the medications your insurance will cover. Many medications now require prior authorization. It is IMPORTANT that you discuss your current medications with your Dr./ARNP as soon as possible. In some instances your Dr./ARNP may be required to substitute different medications from what you currently have prescribed. The PDL is posted on the Internet at http://ahca.myflorida.com.

Per AHCA:
Mental Health Drugs
  • Participants taking mental health drugs in the anti-psychotic class that were not approved for the PDL will have a 60-day transition period beginning July 11, 2005. These drugs are: Zyprexa and Symbyax. As with all other medicines, a prior authorization process will remain in place for these drugs.
  • To ensure patients taking anti-depressant medications will have access to a broad selection of brand name and generic drugs, the Agency requested renegotiated pricing from the manufacturers of anti-depressant medications whose drugs were not recommended by the P&T Committee.
  • AHCA will ask the P&T Committee to reopen and reconsider the anti-depressant class at their next meeting in September. Therefore, patients taking Paxil, Lexapro and Zoloft will be allowed to continue taking those drugs at this time.
  • However, Medicaid participants who currently take the anti-depressant drugs Cymbalta, Effexor XR, Prozac Weekly or Sarafem will be given the same transition period of 60 days beginning July 11, 2005. As with all other medicines, a prior authorization process will remain in place for these drugs.

    AHCA has an Ombudsman to assist Medicaid Recipients who are having problems with the Preferred Drug List:
    The toll free number is (866) 490-1901

.........................................................................................................................

Research Into Recovery From Mental Illness

The Harbor and the College of Public Health at the University of South Florida are working together in an exciting opportunity. We are conducting a study that investigates what recovery means to persons who receive mental health services. This study will help to determine what personal, social and treatment factors help a person believe they will recover and what they decide is important for his or her personal recovery. The project requires 350 participants. The study will involve a consumer/client sitting down with a researcher and answering a series of questions from surveys. This is a 60 to 90 minute, one-time commitment and each participant will be paid $10.00 for his or her time. The study will begin towards the end of July or the beginning of August. The lead researcher, Gary Walby, is familiar with the Harbor as he was a clinician here for nine years. His research team is eager to meet the participants as well. They are John Adams, Amy Bradd, Jessica Burns, and Christina Rickus. Because this study has to be done using scientific principles, each participant will be randomly selected. This means that if you get something in the mail or are given a letter by your primary provider (e.g. therapist, case manager), you were selected randomly to participate. This does not mean that you have to participate, as it is completely voluntary. However, this information is important to improving the understanding of what it is like to recover from a mental illness, and we hope you will participate.
The Harbor works closely with NAMI who is a nonprofit, grassroots, self-help, support and advocacy organization made up of consumers, families, and friends of people with severe mental illnesses, such as schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, panic and other severe anxiety disorders, autism and pervasive developmental disorders, attention deficit/hyperactivity disorder, and other severe and persistent mental illnesses that affect the brain.
 
 
 
 
 
 
 
   

Past Harbor Happenings

Winter 2005




 
 


2006 The Harbor Behavioral Health Care